The $0.33 Is The Price At Which Kiromic BioPharma Inc. (NASDAQ: KRBP) Deserves Consideration – Marketing Sentinel
Home  »  Technologies   »  The $0.33 Is The Price At Which Kiromic BioPharma ...

The $0.33 Is The Price At Which Kiromic BioPharma Inc. (NASDAQ: KRBP) Deserves Consideration

During the last session, Kiromic BioPharma Inc. (NASDAQ:KRBP)’s traded shares were 0.44 million. At the end of the trading day, the stock’s price was $0.33, reflecting an intraday loss of -11.49% or -$0.05. The 52-week high for the KRBP share is $11.00, that puts it down -3233.33 from that peak though still a striking 9.09% gain since the share price plummeted to a 52-week low of $0.30. The company’s market capitalization is $6.59M, and the average trade volume was 345.65K shares over the past three months.

Kiromic BioPharma Inc. (NASDAQ:KRBP) trade information

Kiromic BioPharma Inc. (KRBP) registered a -11.49% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -11.49% in intraday trading to $0.33 this Friday, 05/13/22, hitting a weekly high. The stock’s 5-day price performance is -34.78%, and it has moved by -60.68% in 30 days. Based on these gigs, the overall price performance for the year is -94.23%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Kiromic BioPharma Inc. (KRBP) estimates and forecasts

Statistics show that Kiromic BioPharma Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Kiromic BioPharma Inc. (KRBP) shares have gone down -88.91% during the last six months, with a year-to-date growth rate more than the industry average at 1.36% against -0.10.

While earnings are projected to return 16.70% in 2022.

KRBP Dividends

Kiromic BioPharma Inc. is due to release its next quarterly earnings between March 29 and April 04. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Kiromic BioPharma Inc. (NASDAQ:KRBP)’s Major holders

Kiromic BioPharma Inc. insiders own 23.12% of total outstanding shares while institutional holders control 22.28%, with the float percentage being 28.98%. Kepos Capital Lp is the largest shareholder of the company, while 26 institutions own stock in it. As of Sep 29, 2021, the company held over 0.77 million shares (or 4.97% of all shares), a total value of $2.35 million in shares.

The next largest institutional holding, with 0.48 million shares, is of Sabby Management, LLC’s that is approximately 3.10% of outstanding shares. At the market price on Sep 29, 2021, these shares were valued at $1.47 million.

Also, the Mutual Funds coming in first place with the largest holdings of Kiromic BioPharma Inc. (KRBP) shares are Vanguard Total Stock Market Index Fund and Fidelity NASDAQ Composite Index Fund. Data provided on Sep 29, 2021 indicates that Vanguard Total Stock Market Index Fund owns about 0.28 million shares. This amounts to just over 1.83 percent of the company’s overall shares, with a $0.87 million market value. The same data shows that the other fund manager holds slightly less at 36662.0, or about 0.24% of the stock, which is worth about $81756.0.

Leave a Comment

Your email address will not be published.

On Key

Related Posts